AGM today and starting to tick up.



http://www.mediwatch.com/

now looking good

Wow - up 15% today alone, not forgetting the 100% when the US deal's announced :-)

Looking good indeed.

Just noticed the reason for today's rise - a nice distribution deal for the UK to keep us sweet until the "BIG ONE":

Mediwatch PLC
02 September 2004


SONOSITE AND MEDIWATCH SIGN DISTRIBUTION AND DEVELOPMENT AGREEMENTS FOR UROLOGY
MARKET

Mediwatch to Distribute SonoSite Products to UK Urology Market

SonoSite Technology to be Incorporated into Mediwatch's Prostate Assessment
Product

LONDON, September 2, 2004 - SonoSite Inc. (Nasdaq: SONO), the worldwide leader
in high performance, hand-carried ultrasound, announced today that SonoSite,
Ltd., the Company's United Kingdom (UK) subsidiary, has entered into two
distribution and supply agreements with Mediwatch Plc., (LSE:MDW.L) a leading
developer, manufacturer and distributor of advanced urological primary care
products for the screening, diagnosis and assessment of urological disease and
disorders.

Under the terms of the first agreement, Mediwatch will become an authorised
distributor of SonoSite's hand-carried ultrasound systems for the UK urology
market. Pursuant to the second agreement, SonoSite will supply Mediwatch with
its TITAN(TM) ultrasound technology to be incorporated into Mediwatch's proprietary
'One Stop' Prostate Assessment System, which is currently under development and
Mediwatch intends to market worldwide when completed. Mediwatch's 'One Stop'
Prostate Assessment System is designed to provide the physician with a complete
system for the diagnosis and assessment of prostate health in the clinic and
will include imaging, urinalysis and blood testing capabilities.

'Teaming up with Mediwatch enables SonoSite to rapidly and cost-effectively
expand our presence in the highly demanding, specialized UK urology market,'
said Graham Cox, SonoSite Vice President, European Sales. 'We believe that our
high performance ultrasound technology can play a significant role in aiding
physicians with the early detection and management of prostate tumours and other
urological conditions. Additionally, the incorporation of SonoSite's technology
into Mediwatch's new 'One Stop' Prostate Assessment System, provides the
opportunity for us to establish a significant position in the worldwide urology
market.'

'SonoSite has led the ultrasound imaging market in providing clinicians with
high quality, affordable ultrasound that is designed to be easily and
efficiently used in the physician's office, hospital or carried to the
point-of-care,' said Philip Stimpson, CEO of Mediwatch Plc. 'By integrating
their technology with our 'One Stop' clinical system, we can provide physicians
with a total solution for assessment of prostate health.'


CONTACTS:

SonoSite (U.K.): Graham Cox, 01462 444 800,
graham.cox@sonosite.com
SonoSite (U.S.): Mike Schuh, 001 425 951 1333,
investor@sonosite.com
Mediwatch: Philip Stimpson, 01788 547 888,
philip.stimpson@mediwatch.com


-ends -

It looks as though MDW has found a relatively stable bottom again, though I reckon most folks who bought in for the big news must have been stopped out by now.

Looks like a good time to scoop up another chunk, which I may well do next week. As each day goes on we get closer and closer to that "massive" US distribution deal - who knows, it could be announced next week.

hope you are right overgrowth.....might start pestering mr stimpson for some news this week1!!!

got a feeling when/if this US deal is announced it will rocket to some extent....however more importantly these distribution deals bring in some good sales,.

Large markup by the MMs today - up 13% at close.

Is there something finally brewing ?

overgrowth...distribution deals!!!. Let's hope it is just the beginning:-))
Will have to retrieve the shares from the dog drawer!!

Great news eh Jules ?

China and Hong Kong no less. China could well end up being bigger than a distribution deal in the US.

What a crap day to announce the news though - the price rise has been falsely deflated. I reckon there's plenty more upside to come when folks calculate the future projections for these deals - so still worth buying in tomorrow imho (for you guys waiting on the sidelines).

A bit of coverage over the next few days in the papers.... hopefully,and a few more +ive statements from mdw then who knows?Been a long wait but things are starting to look good-imo.Still a long way to go me thinks in mdw achieving what they set out for.....but getting to the first rung is very good!

banjomick - Still a long way to go before we see the price at 1+

Though, now MDW are coming up with the goods big style, 1 doesn't seem all that far away :-)

lol OG a ,but then again.....Think it may go up a few more pence this week on todays news alone but will require further news on the actual deal to double.If they get the USA deal,which was on the cards earlier on this year,then obviously 1 and above would be,can i use my fav.,word-lol,verisimilitude!!!!

Blimey banjomick, I had to resort to the dictionary on that one - quite appropriate though.

A few sellers today who probably were happy to double their money after getting in at the 3p level much earlier.

There should be plenty more buying next when the news sinks in. MDW is now looking interesting enough to be a future "Play of the Week" in Shares mag.

If MDW are already shipping products to China and Hong Kong, they must be antcipating selling a good few products very soon - the next results should be excellent and future growth potential is now phenomenal.

Can understand the sellers today but even in the short/medium term there should be room for a substantial rise especially if they do it right and give frequent updates (+ve ones)to let shareholders know whats happening(unlike GON-lol).Lets hope for a bit of press coverage over w/end!No more big words,it is the only one I know-lol

i am sure they will require another placing?
any thoughts?

petravla - 50:50 I would say.

The last placing was to cover stock for the US deal - this can be used for the China/Hong Kong deal now.

It all depends on how long the US distribution deal takes to finalise. If substantial profits are coming in from China/Hong Kong then this will cover stock in the US, otherwise they'll need to raise some temporary finance to keep growing at a rapid pace.

Has anyone any knowledge of the market which MDW have just moved into ?

Hong Kong has a population of 6.8 million at the last count and China 1.285 billion - I wonder what proportion of this will turn into sales for MDW....

Looks like stake building at the moment 2 x 250k buys @ 7.5 the other day now 2 taday @ 6.5?

someones happy with 70k in mediwatch.....not the sort of money you would invest if at all unconfident of the future. bodes well!

bought these beginning of sept with hindsight had I waited 2 mins would not have bought,soon as I bought they dropped the 2p they had risen that day,now I am locked in 45% down but I do believe there is some profit coming (keep the faith)

mort - I'm a fair bit down too, however MDW are really worth holding on to.

Bullish statements have been made by Philip Stimpson (CEO) on various occasions in the past and most of these are starting to take shape. The company is just starting to fulfil its ambitions of being a spectacular growth story.

At one point the press rumoured that PS had said that MDW would be 1 by this Christmas (this was when he thought that the US distribution deal was in the bag), this is not on the cards just yet, however the US deal has yet to be announced so 1 sometime next year is not totally beyond the realms of possibility.

MDW's goal is to sell their products in 100 different countries. They have a solid niche medical product range (which already sells well in the UK and Europe) and are destined to go far in the next couple of years.

This is great news folks....and it's not even the much awaited US distribution contract or the Chinese approval - we've got these to still look forward to.

This proves that the management are all out to make Mediwatch a global force to be reckoned with. This is a good sized order for a relatively small company growing rapidly.

Also great to hear "The contract also confirms that Mediwatch equipment is regarded as a sector leader by one of the most successful medical companies in the world.".

Price up 16% today, though there's going to be much, much more to come!


RNS Number:5009E
Mediwatch PLC
27 October 2004


Mediwatch receives 1 million equipment order.


DATE: 27th October 2004.


Mediwatch plc (AIM: MDW), the high-tech medical diagnostic equipment
manufacturer and supplier has received a 1 million order as part of a five year
supply agreement with Bard Limited, one of the world's leading developers and
marketers of medical equipment.

Mediwatch will supply the British subsidiary of major US medical equipment
distributor C.R.Bard Inc (NYSE: BCR) with its range of portable bladder
scanners.

The contract also confirms that Mediwatch equipment is regarded as a sector
leader by one of the most successful medical companies in the world.

Said Mediwatch CEO Philip Stimpson: " The technology we provide is increasingly
being recognised as some of the best in the business."

"This order demonstrates Mediwatch's ability to supply clinicians with the
latest, innovative, diagnostic solutions, harnessing technology to provide
patients with better medical care"

Mediwatch, based in Rugby, supplies advanced yet simple to use medical equipment
to screen for a variety of urological disorders. It is also developing a new,
smaller and cheaper PSA test for prostate disease.

Their innovative range of products includes:

* One Stop Prostate Assessment System - offering a quick and comprehensive
assessment of both prostate and bladder function with an integrated radio link
to other equipment.

* Portaflow - available in both Portable and Advanced versions which provide
clinicians with an immediate assessment of urinary flow rate in patients with
lower urinary tract symptoms.

* Portascan - a portable, battery-operated, dedicated bladder scanner which
measures bladder volumes and has the ability to store and print up to 20
images.

* Urosonic - available in both Portable and Advanced versions for assessment of
the bladder, prostate, kidney and testes, with a new pelvic floor module.


With increasing life expectancy and an ageing population, prostate and
urological conditions are among the fastest growing health problems encountered
by doctors today.


For more information, please contact Mediwatch CEO Philip Stimpson on:
01788-547888 .


Also, log on to our website: www.mediwatch.com.


Ends